The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

In this interview live from the floor of the RIU Explorers Conference for 2026, Black Canyon Ltd (ASX:BCA) managing director Brendan Cummins tells HotCopper what the company’s manganese and iron discovery means.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

In Cummins’ words, Black Canyon is sitting on what could potentially be the major manganese and iron find of the 21st Century when it comes to Western Australia’s rich mineral history.

Tune in to hear more from Brendan about the Aussie company’s wins across CY25, why the company is fielding institutional interest, and what lies ahead in the coming weeks and months.

Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

bca by the numbers
More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)